MOVEMENT DISORDERS, published by Wiley, stands as a premier outlet for cutting-edge research in the field of neurology, particularly focusing on the various aspects of movement disorders. With both its ISSN (0885-3185) and E-ISSN (1531-8257) identifiers, this journal is at the forefront of neurological research, holding a remarkable impact factor and recognized in the top quartiles (Q1) of the disciplines of Neurology and Clinical Neurology as of 2023. The journal boasts an impressive Scopus ranking, placing it in the top 8 out of 192 for Neuroscience-Neprology and 19 out of 400 for Medicine-Clinical Neurology, reflecting its high relevance and influence in the field. Released quarterly since its inception in 1986 and continuing through 2024, MOVEMENT DISORDERS publishes a mix of original research articles, reviews, and case reports that catalyze innovation and foster collaboration among researchers, healthcare professionals, and students dedicated to understanding and treating movement disorders. As a non-open access journal, it nevertheless offers valuable insights that are essential for the advancement of knowledge in neurology, making it a critical resource for anyone invested in this challenging and evolving field.

Clinical Genitourinary Cancer, published by CIG MEDIA GROUP, LP, is a leading journal in the fields of Oncology and Urology, with an impressive impact reflected in its quartile rankings (Q2 in Oncology and Q1 in Urology for 2023) and strong Scopus rankings (22nd in Urology and 162nd in Oncology). The journal aims to innovate and inspire new research in genitourinary malignancies, providing a platform for the latest findings in diagnosis, treatment, and patient management. With its commitment to high-quality publications since its establishment in 2005, Clinical Genitourinary Cancer serves a crucial role in advancing the understanding of these complex conditions and enhancing clinical practices. Researchers, professionals, and students in the medical community are encouraged to engage with this essential resource, which facilitates open access to pioneering studies that drive the field forward.

Epilepsia Open is a premier open access journal dedicated to advancing the field of neurology, particularly in the area of epilepsy research and clinical practice. Published by WILEY since 2016, this journal aims to provide a platform for high-quality, peer-reviewed research that fosters collaboration among researchers, clinicians, and educators within the global neurological community. With an impactful presence in the field, it holds a prestigious Q2 ranking in both Neurology and Clinical Neurology categories as of 2023 and has been recognized for its contributions to the understanding of epilepsy through its diverse range of articles, reviews, and clinical studies. Researchers and practitioners can benefit from the journal's open access model, which ensures that valuable findings are readily available to the public, promoting further developments in treatment and care. The journal's significant visibility is reflected in its Scopus rankings, where it ranks in the top half of peer-reviewed journals in both Neurology and Neuroscience categories. For those committed to improving the lives of those affected by epilepsy, Epilepsia Open represents a crucial resource for cutting-edge knowledge and innovative practices.

Clinical and Experimental Gastroenterology is a prestigious Open Access journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the field of gastroenterology through rigorous research and innovative insights. With its ISSN 1178-7023, the journal has established a significant presence since its inception in 2008 and has been actively contributing to the academic landscape from New Zealand. The journal has attained a commendable Q2 rank in the Gastroenterology category as of 2023, placing it in the upper-tier percentile of similar journals. It currently ranks #57 out of 167 in the Scopus database, highlighting its relevance and impact in the field at the 66th percentile. Encompassing a wide range of topics within gastroenterology, the journal aims to foster discussion and disseminate findings that enhance clinical practices and patient care. Researchers, healthcare professionals, and students alike will find this journal an invaluable resource for cutting-edge research and developments in gastrointestinal health.

CLINICAL NEUROLOGY AND NEUROSURGERY, published by Elsevier, is a pivotal journal in the fields of neurology and neurosurgery, recognized for its rigorous peer-review process and commitment to advancing clinical practices. Established in 1974, the journal has become a respected source of innovative research, evidenced by its excellent Scopus rankings—placing it within the top half of journals in both Medicine (Surgery) and the clinical aspect of Neurology. Notably, it has achieved a Q2 ranking in both Medicine (miscellaneous) and Surgery, and Q3 in Neurology (clinical) as of 2023. The journal publishes a wide array of articles focused on the latest findings, clinical practices, and technological advancements that address neurological disorders and surgical interventions. While it does not currently operate under an open-access model, it remains highly accessible to academic institutions and professionals worldwide from its editorial base in the Netherlands. By enabling knowledge-sharing and fostering collaboration among researchers, practitioners, and students, CLINICAL NEUROLOGY AND NEUROSURGERY plays a crucial role in shaping the future of clinical neurology and surgical techniques.

CLINICAL NEUROPHARMACOLOGY, published by Lippincott Williams & Wilkins, stands as a premier journal dedicated to advancing the understanding of pharmacological interventions in the realm of neurology. With its ISSN 0362-5664 and E-ISSN 1537-162X, this journal has been a vital resource since its inception in 1982, consistently contributing valuable research and reviews to the fields of clinical neurology and pharmacology. As reflected in its 2023 Quartile Ranking of Q3 in neuroscience and pharmacological categories, CLINICAL NEUROPHARMACOLOGY plays a crucial role in disseminating knowledge among researchers and clinicians alike, showcasing innovative studies that enhance therapeutic practices. The journal promotes rigorous peer-reviewed scholarship and emphasizes access to cutting-edge findings, making it an essential read for professionals aiming to bridge the gap between research and clinical application. Although it operates on a subscription model, the depth and quality of research it presents ensure its significance and utility in advancing the science of neurological pharmacotherapy. For anyone invested in the synergy of pharmacology and neurology, CLINICAL NEUROPHARMACOLOGY is the premier destination for insightful and impactful scholarly communication.

Orthopedic Research and Reviews is a leading open-access journal dedicated to advancing the field of orthopedics and sports medicine, published by DOVE MEDICAL PRESS LTD since 2009. Situated in New Zealand, this journal has established itself as an essential resource for researchers, practitioners, and students alike, facilitating the dissemination of high-quality research and reviews in orthopedics. With a commendable impact factor reflected in its 2023 ranking in the Q2 quartile of orthopedics, the journal ranks #155 out of 321 in its category on Scopus, placing it in the 51st percentile among peers. The journal aims to publish cutting-edge findings and comprehensive reviews that contribute to the understanding and treatment of musculoskeletal disorders. As an open-access publication, it ensures that vital research is accessible to a global audience, underscoring its commitment to innovation and education in the orthopedic community. Researchers and professionals are encouraged to submit their work, as the journal continues to expand its influence and relevance in the evolving landscape of orthopedic medicine.

The Journal of Clinical Sleep Medicine, published by the American Academy of Sleep Medicine, is a premier platform for cutting-edge research in the fields of neurology and pulmonary and respiratory medicine. With a commendable impact factor reflective of its robust scholarly output, this journal plays a crucial role in disseminating knowledge that directly influences clinical practices and enhances patient care for sleep-related disorders. Since its inception in 2005, the journal has maintained a strong reputation, currently holding a Q2 ranking in Neurology and a top-tier Q1 designation in both Clinical Neurology and Pulmonary and Respiratory Medicine. The journal is indexed in Scopus and ranks in the top 25 percentile among its peers, underscoring its importance and influence in the scientific community. Although it does not offer open access, the articles are available through institutional subscriptions, making essential findings accessible to a wide audience of researchers, medical professionals, and students committed to advancing the understanding of sleep medicine.

The International Journal of Chronic Obstructive Pulmonary Disease, published by DOVE MEDICAL PRESS LTD, serves as a premier platform for researchers and professionals involved in the study and management of COPD. Established in 2006 and transitioning to an Open Access model in 2009, this journal has quickly gained a reputable standing in various impactful categories, achieving Q1 rankings in Health Policy, Medicine (Miscellaneous), and Public Health, among others. With a focus on disseminating high-quality research, the journal is pivotal for addressing global public health challenges associated with chronic obstructive pulmonary disease. The journal's dedication to open access ensures that vital information reaches a broader audience, fostering advancements in research and clinical practice. By maintaining rigorous peer-review standards and a commitment to the advancement of understanding in COPD, the journal attracts significant contributions from scientists and practitioners worldwide, making it an invaluable resource for ongoing education and research development in this critical area.

Annals of Dermatology is a prestigious academic journal published by the Korean Dermatological Association, focusing on the latest research and advancements in the field of dermatology. With a commitment to advancing knowledge in skin health and disease, this journal serves as a vital resource for researchers, clinicians, and students working in dermatology and related disciplines. Since its inception in 1989, it has evolved to consolidate its position in the academic community, boasting a Q2 ranking in the 2023 Dermatology category and a Scopus rank of #87 out of 142, placing it in the 39th percentile. Although it operates under a subscription model, the journal's impact factor reflects its significance in advancing dermatological research, attracting innovative studies and reviews that shape clinical practice. With a publication history extending from 1989 to 1996 and then from 2008 to the present, Annals of Dermatology continues to be an essential publication for those devoted to improving skin health.